Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ODS Office Relocation Meant To Accommodate Staffing Increase

This article was originally published in The Tan Sheet

Executive Summary

NIH's Office of Dietary Supplements is moving to a new location due to increased staff size and anticipated continued growth

You may also be interested in...



ODS new address

NIH's Office of Dietary Supplements' move has been completed (1"The Tan Sheet, June 10, 2002, p. 8); the new address is National Institutes of Health, 6100 Executive Blvd., Room 3B01, MSC 7517, Bethesda, Md., 20892...

ODS new address

NIH's Office of Dietary Supplements' move has been completed (1"The Tan Sheet, June 10, 2002, p. 8); the new address is National Institutes of Health, 6100 Executive Blvd., Room 3B01, MSC 7517, Bethesda, Md., 20892...

ODS new address

NIH's Office of Dietary Supplements' move has been completed (1"The Tan Sheet, June 10, 2002, p. 8); the new address is National Institutes of Health, 6100 Executive Blvd., Room 3B01, MSC 7517, Bethesda, Md., 20892...

Related Content

Topics

UsernamePublicRestriction

Register

PS094125

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel